Anzeige
Mehr »
Login
Dienstag, 11.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
218 Leser
Artikel bewerten:
(1)

InjuryClaims.com Connects Oxbryta Users to Legal Help After Recall

Finanznachrichten News

If you've experienced serious side effects from Oxbryta, find out if you qualify for compensation.

CHEYENNE, WY / ACCESSWIRE / October 23, 2024 / InjuryClaims.com is connecting people who may have been harmed by the recalled drug Oxbryta to experienced legal support. Our partner law firms, including Cory Watson Attorneys-a respected national firm known for handling dangerous drug cases-are now reviewing claims from individuals who may qualify for compensation related to Oxbryta injuries.

Oxbryta, approved in 2019 to treat sickle cell disease, was intended to reduce pain and improve red blood cell health. However, recent clinical trials revealed that the drug was linked to increased risks of death and serious health issues, such as vaso-occlusive crises (VOCs). These findings led Pfizer to recall the drug from the market in September 2024.

What to Know About Oxbryta's Side Effects

For many living with sickle cell disease, managing pain and health complications is already a significant challenge. Oxbryta was marketed as a way to prevent VOCs by helping red blood cells carry more oxygen, but data now suggests it may have caused more harm than good.

Some patients taking Oxbryta experienced:

  • Vaso-occlusive crises (VOC)

  • Severe pain and discomfort

  • Hospitalization

  • Stroke

  • Kidney failure

  • Death

If you or someone you know took Oxbryta and experienced these complications, you may be eligible to file a claim. Injury Claims can help you connect with one of its partner law firms for a free consultation to understand your legal options.

How to Get Legal Support

Injury Claims encourages those affected by Oxbryta to learn more about their rights and eligibility for compensation. By reaching out, you can be connected with one of our partner law firms, which will provide a confidential consultation at no cost. Visit Injuryclaims.com or explore ongoing Oxbryta claims at Class Action Lawsuits.

InjuryClaims.com is committed to assisting those harmed by dangerous drugs. If Oxbryta caused you harm, let us help you take the first step toward possible compensation.

Get started here today.

CONTACT:
Gino Aielli
Typhon Interactive
Phone: (307) 213-4486
Email: info@typhoninteractive.com

SOURCE: injuryclaims.com



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.